Circulation of endemic type 2 vaccine-derived poliovirus in Egypt from 1983 to 1993
- PMID: 12857906
- PMCID: PMC165252
- DOI: 10.1128/jvi.77.15.8366-8377.2003
Circulation of endemic type 2 vaccine-derived poliovirus in Egypt from 1983 to 1993
Abstract
From 1988 to 1993, 30 cases of poliomyelitis associated with poliovirus type 2 were found in seven governorates of Egypt. Because many of the cases were geographically and temporally clustered and because the case isolates differed antigenically from the vaccine strain, it was initially assumed that the cases signaled the continued circulation of wild type 2 poliovirus. However, comparison of sequences encoding the major capsid protein, VP1 (903 nucleotides), revealed that the isolates were related (93 to 97% nucleotide sequence identity) to the Sabin type 2 oral poliovirus vaccine (OPV) strain and unrelated (<82% nucleotide sequence identity) to the wild type 2 polioviruses previously indigenous to Egypt (last known isolate: 1979) or to any contemporary wild type 2 polioviruses found elsewhere. The rate and pattern of VP1 divergence among the circulating vaccine-derived poliovirus (cVDPV) isolates suggested that all lineages were derived from a single OPV infection that occurred around 1983 and that progeny from the initiating infection circulated for approximately a decade within Egypt along several independent chains of transmission. Complete genomic sequences of an early (1988) and a late (1993) cVDPV isolate revealed that their 5' untranslated region (5' UTR) and noncapsid- 3' UTR sequences were derived from other species C enteroviruses. Circulation of type 2 cVDPVs occurred at a time of low OPV coverage in the affected communities and ceased when OPV coverage rates increased. The potential for cVDPVs to circulate in populations with low immunity to poliovirus has important implications for current and future strategies to eradicate polio worldwide.
Figures






Similar articles
-
Sabin Vaccine Reversion in the Field: a Comprehensive Analysis of Sabin-Like Poliovirus Isolates in Nigeria.J Virol. 2015 Oct 14;90(1):317-31. doi: 10.1128/JVI.01532-15. Print 2016 Jan 1. J Virol. 2015. PMID: 26468545 Free PMC article.
-
Circulation of type 1 vaccine-derived poliovirus in the Philippines in 2001.J Virol. 2004 Dec;78(24):13512-21. doi: 10.1128/JVI.78.24.13512-13521.2004. J Virol. 2004. PMID: 15564462 Free PMC article.
-
Circulating vaccine-derived polioviruses: current state of knowledge.Bull World Health Organ. 2004 Jan;82(1):16-23. Epub 2004 Feb 26. Bull World Health Organ. 2004. PMID: 15106296 Free PMC article. Review.
-
Multiple independent emergences of type 2 vaccine-derived polioviruses during a large outbreak in northern Nigeria.J Virol. 2013 May;87(9):4907-22. doi: 10.1128/JVI.02954-12. Epub 2013 Feb 13. J Virol. 2013. PMID: 23408630 Free PMC article.
-
Wild and vaccine-derived poliovirus circulation, and implications for polio eradication.Epidemiol Infect. 2017 Feb;145(3):413-419. doi: 10.1017/S0950268816002569. Epub 2016 Nov 21. Epidemiol Infect. 2017. PMID: 27866483 Free PMC article. Review.
Cited by
-
Oral poliovirus vaccine evolution and insights relevant to modeling the risks of circulating vaccine-derived polioviruses (cVDPVs).Risk Anal. 2013 Apr;33(4):680-702. doi: 10.1111/risa.12022. Epub 2013 Mar 7. Risk Anal. 2013. PMID: 23470192 Free PMC article.
-
Reemergence of enterovirus 71 in 2008 in taiwan: dynamics of genetic and antigenic evolution from 1998 to 2008.J Clin Microbiol. 2009 Nov;47(11):3653-62. doi: 10.1128/JCM.00630-09. Epub 2009 Sep 23. J Clin Microbiol. 2009. PMID: 19776232 Free PMC article.
-
Environmental surveillance of Non-Polio Enteroviruses in Iran.Virol J. 2009 Sep 25;6:149. doi: 10.1186/1743-422X-6-149. Virol J. 2009. PMID: 19781063 Free PMC article.
-
Genetic characterization and molecular epidemiological analysis of novel enterovirus EV-B80 in China.Emerg Microbes Infect. 2018 Nov 28;7(1):193. doi: 10.1038/s41426-018-0196-9. Emerg Microbes Infect. 2018. PMID: 30482903 Free PMC article.
-
Recombination in Enteroviruses, a Multi-Step Modular Evolutionary Process.Viruses. 2019 Sep 14;11(9):859. doi: 10.3390/v11090859. Viruses. 2019. PMID: 31540135 Free PMC article. Review.
References
-
- Alexander, J. P., Jr., H. E. Gary, Jr., and M. A. Pallansch. 1997. Duration of poliovirus excretion and its implications for acute flaccid paralysis surveillance: a review of the literature. J. Infect. Dis. 175(Suppl. 1):S176-S182. - PubMed
-
- Aylward, R. B., D. Porta, L. Fiore, B. Ridolfi, P. Chierchini, and F. Forastiere. 1997. Unimmunized Gypsy populations and implications for the eradication of poliomyelitis in Europe. J. Infect. Dis. 175(Suppl. 1):S86-S88. - PubMed
-
- Balanant, J., S. Guillot, A. Candréa, F. Delpeyroux, and R. Crainic. 1991. The natural genomic variability of poliovirus analyzed by a restriction fragment polymorphism assay. Virology 184:645-654. - PubMed
-
- Bellmunt, A., G. May, R. Zell, P. Pring-Akerblom, W. Verhagen, and A. Heim. 1999. Evolution of poliovirus type I during 5.5 years of prolonged enteral replication in an immunodeficient patient. Virology 265:178-184. - PubMed
-
- Centers for Disease Control and Prevention. 2000. Developing and expanding contributions of the Global Laboratory Network for Poliomyelitis Eradication, 1997-1999. Morb. Mortal. Wkly. Rep. 49:156-160. - PubMed
Publication types
MeSH terms
Substances
Associated data
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical